BeiGene Market Cap

BeiGene has a market cap or net worth of 181.32 billion as of May 13, 2025. Its market cap has increased by 61.23% in one year.

Market Cap

181.32B

Enterprise Value

170.38B

Revenue

30.30B

Ranking

n/a

PE Ratio

n/a

Stock Price

232.98

Market Cap Chart

Since February 3, 2016, BeiGene's market cap has increased from 5.65B to 181.32B, an increase of 3,110.04%. That is a compound annual growth rate of 45.34%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	181.32B	26.31%
Dec 31, 2024	143.55B	7.76%
Dec 29, 2023	133.21B	-15.45%
Dec 30, 2022	157.55B	-10.93%
Dec 31, 2021	176.88B	15.32%
Dec 31, 2020	153.38B	117.37%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	335.80B
Shenzhen Mindray Bio-Medical Electronics	270.90B
WuXi AppTec	168.36B
Zhangzhou Pientzehuang Pharmaceutical.,	125.22B
Aier Eye Hospital Group	119.56B
Sichuan Biokin Pharmaceutical	112.28B
Shanghai United Imaging Healthcare	112.08B
Yunnan Baiyao Group Co.,Ltd	101.81B

Market Cap Rankings